6505--Adalimumab Pen/Syringe Kits
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 36E79723R0038
- Agency
- National Acquisition Center Headquarters, Department of Veterans Affairs
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The VA National Acquisition Center intends to issue solicitation number 36E79723R0038 on October 12, 2023 seeking offers for a one-year contract plus four one-year option periods to provide an uninterrupted supply of Adalimumab pen and syringe kits for the Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service. Offerors must be able to supply the exact drug name and have a unique NDC number, and the contract will be awarded to the responsible offeror who can ensure supply. Proposals are due by October 26, 2023. Interested parties should monitor sam.gov for any amendments and direct questions to Christopher Carthron by email.
The estimated annual requirements total 120,089 kits of 40mg/0.4ml pens, 9,715 kits of 40mg/0.4ml syringes, 149,641 kits of 40mg/0.8ml pens, and 23,595 kits of 40mg/0.8ml syringes. There is no set-aside designation. The primary NAICS code is 325412 for pharmaceutical preparation manufacturing. The estimated total contract value will depend on agency demand but quantities provided indicate multi-million dollar awards are possible over the five-year period of performance.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0038 for an unrestrictive procurement for Adalimumab Pen/Syringe Kits, for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79723R0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 12, 2023, with a tentative closing date of October 26, 2023. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to: Christopher.Carthron@va.gov.
The estimated annual requirements are as follows:
Item Description Size Estimated Annual Requirements
(Kits)
Group I
ADALIMUMAB 40MG/0.4ML INJ,PEN,KIT 2 120,089
ADALIMUMAB 40MG/0.4ML INJ,SYRINGE,KIT 2 9,715
Group II
1 ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT 2 149,641
2 ADALIMUMAB 40MG/0.8ML INJ,SYRINGE,KIT 2 23,595
*Group I and Group II do not have to be awarded to the same vendor.
Attachments
| File | Type | Posted |
|---|---|---|
| 36E79723R0038_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Adalimumab Pen/Syringe Kits | Award Notice | |
| 6505--Adalimumab Pen/Syringe Kits | Solicitation | |
| 6505--Adalimumab Pen/Syringe Kits | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity